Ultragenyx Pharmaceutical (RARE) Net Cash Flow (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) posted Net Cash Flow of -$53 million for Q2 2026, compared with $45.84 million a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Net Cash Flow (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Cash Flow at Ultragenyx Pharmaceutical was -$51 million; for FY2025, it came in at $248 million.
- Annual Net Cash Flow shows a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Net Cash Flow was -$33 million in FY2024, $81 million in FY2023, -$170.91 million in FY2022 and -$415.52 million in FY2021.
- Quarterly Net Cash Flow has run from a low of -$331.32 million in Q3 2024 to a high of $368.54 million in Q2 2024 over five years.
- According to Business Quant data, Net Cash Flow for the three prior quarters was -$246 million (Q1 2026), $222.12 million (Q4 2025) and $25.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | -53.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.00 Mn |
| Mar 31, 2026 | -246.00 Mn |
| Dec 31, 2025 | 222.12 Mn |
| Sep 30, 2025 | 25.88 Mn |
| Jun 30, 2025 | 45.84 Mn |
| Mar 31, 2025 | -45.84 Mn |
| Dec 31, 2024 | 26.13 Mn |
| Sep 30, 2024 | -331.32 Mn |
| Jun 30, 2024 | 368.54 Mn |
| Mar 31, 2024 | -96.35 Mn |
| Dec 31, 2023 | 139.35 Mn |
| Sep 30, 2023 | -28.35 Mn |
| Jun 30, 2023 | 16.28 Mn |
| Mar 31, 2023 | -46.29 Mn |
| Dec 31, 2022 | -260.06 Mn |
| Sep 30, 2022 | 234.67 Mn |
| Jun 30, 2022 | 7.75 Mn |
| Mar 31, 2022 | -153.27 Mn |
| Dec 31, 2021 | 100.44 Mn |
| Sep 30, 2021 | -92.86 Mn |
API Access
Ultragenyx Pharmaceutical Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();